DOCSLIB.ORG

Case Definitions for Communicable Morbidities

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Case Definitions for Communicable Morbidities Case Definitions for Communicable Morbidities 2017 TABLE OF CONTENTS Introduction ............................................................................................................................................................... 5 Definition of Terms Used in Case Classification ................................................................................................ 6 Definition of an Epidemiologic Investigation ....................................................................................................... 6 Definition of Binational Case ................................................................................................................................. 7 Case Definitions for Communicable Morbidities Reportable in Arizona ......................................................... 8 AMEBIASIS ........................................................................................................................................................... 9 ANTHRAX (Bacillus anthracis) ............................................................................................................................ 11 ARBOVIRAL DISEASES (including WEST NILE VIRUS) ................................................................................... 13 ASEPTIC MENINGITIS (viral) ............................................................................................................................. 19 BASIDIOBOLOMYCOSIS.................................................................................................................................... 20 BOTULISM .......................................................................................................................................................... 21 Botulism, Foodborne ....................................................................................................................................... 21 Botulism, Wound ............................................................................................................................................. 21 Botulism, Other ................................................................................................................................................ 22 BOTULISM, INFANT ........................................................................................................................................... 24 BRUCELLOSIS .................................................................................................................................................... 26 BURKHOLDERIA MALLEI (Glanders) ................................................................................................................ 28 BURKHOLDERIA PSEUDOMALLEI (Melioidosis) .............................................................................................. 29 CAMPYLOBACTERIOSIS .................................................................................................................................. 31 CHAGAS DISEASE ............................................................................................................................................. 33 CHANCROID ....................................................................................................................................................... 36 CHIKUNGUNYA .................................................................................................................................................. 38 CHLAMYDIA TRACHOMATIS INFECTION ........................................................................................................ 39 CHOLERA ........................................................................................................................................................... 41 COCCIDIOIDOMYCOSIS (Valley fever) ............................................................................................................. 43 COLORADO TICK FEVER .................................................................................................................................. 45 CONJUNCTIVITIS, ACUTE ................................................................................................................................. 46 CREUTZFELDT-JAKOB DISEASE ..................................................................................................................... 48 CRYPTOSPORIDIOSIS (Cryptosporidium parvum) ........................................................................................... 51 CYCLOSPORAISIS ............................................................................................................................................. 53 CYSTICERCOSIS ............................................................................................................................................... 55 DENGUE VIRUS INFECTIONS .......................................................................................................................... 56 DIARRHEA, NAUSEA, OR VOMITING ............................................................................................................... 60 DIPHTHERIA ....................................................................................................................................................... 62 EHRLICHIOSIS / ANAPLASMOSIS .................................................................................................................... 64 EMERGING OR EXOTIC DISEASE .................................................................................................................... 67 ENCEPHALITIS, PARASITIC .............................................................................................................................. 69 ENCEPHALITIS, VIRAL ...................................................................................................................................... 71 ENTEROHEMORRHAGIC ESCHERICHIA COLI (EHEC) .................................................................................. 73 ENTEROTOXIGENIC ESCHERICHIA COLI (ETEC) .......................................................................................... 76 FOODBORNE DISEASE OUTBREAK ................................................................................................................ 78 GIARDIASIS ........................................................................................................................................................ 80 GRANULOMATOUS AMEBIC ENCEPHALITIS (GAE), Acanthamoeba Disease excluding keratitis ................ 82 GRANULOMATOUS AMEBIC ENCEPHALITIS (GAE), Balamuthia mandrillaris Disease ................................. 84 GONORRHEA ..................................................................................................................................................... 86 HAEMOPHILUS INFLUENZAE: INVASIVE DISEASE ........................................................................................ 88 HANSEN’S DISEASE (Leprosy) .......................................................................................................................... 90 HANTAVIRUS ...................................................................................................................................................... 92 Hantavirus Pulmonary Syndrome (HPS): ........................................................................................................ 92 Hantavirus infection, non-Hantavirus pulmonary syndrome (non-HPS): ........................................................ 92 HEMOLYTIC UREMIC SYNDROME ................................................................................................................... 94 HEPATITIS A ....................................................................................................................................................... 96 HEPATITIS B, ACUTE ......................................................................................................................................... 98 ADHS Communicable Disease Case Definitions 2 2017 HEPATITIS B, CHRONIC .................................................................................................................................. 100 HEPATITIS B, PERINATAL ............................................................................................................................... 102 HEPATITIS C, ACUTE ...................................................................................................................................... 104 HEPATITIS C, CHRONIC .................................................................................................................................. 106 HEPATITIS D ..................................................................................................................................................... 108 HEPATITIS E ..................................................................................................................................................... 110 HERPES GENITALIS ........................................................................................................................................ 112 HUMAN IMMUNODEFICIENCY VIRUS (HIV) .................................................................................................. 113 2008 Surveillance Case Definition for HIV Infection Among Adults and Adolescents .................................. 113 2008 Surveillance Case Definitions for HIV Infection and AIDS Among Children Aged 18 Months to <13
Load more

Recommended publications
  • Principles and Practice of Public Health Surveillance
    r I P82 " ,Ji<liTin' S PB93-101129 1994 I" PRINCIPLES AND PRACTICE OF PUBLIC HEALTH SURVEILLANCE CENTERS FOR DISEASE CONTROL ATLANTA, GA AUG 92 U.S. DEPARTMENT OF COMMERCE National Technical Information Service \\ P3S3-1C112S Principles and Practice of Public Health Surveillance Steven M. Teutsch R. Elliott Churchill Editors BLDG 10 S. DEPARTMENT OF HEALTH & HUMAN SERVICES CDC Public Health Service Health Lftwy Paiuam »*» Epidemiology Program Office Lane.P.n".. 5600 Fishars Centers for Disease Control 20857 August 1992 Us* of trade naaaa is for identification only and does not constitute endorsement by the Public Health Service or the Centers for Disease Control. Form Approved REPORT DOCUMENTATION PAGE OMB No. 0704-0188 Public reporting burden for this collection of information is estimated to average 1 hour oer response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information Send comments regarding this burden estimate or any other aspect of this 5 collection of information, including suggestions for reducing this burden, to Washington Headouarters Services. Directorate for Information Operations and Reports, 1215 Jefferson L ' " *— Dav — '. andto the Officeof Managementand Budget. Paperwork Reduction Project (0704-0188), Washington. DC 20503 PB9 3-10 1129 2. REPORT DATE 3. REPORT TYPE AND DATES COVERED August 1992 Final 4. TITLE AND SUBTITLE 5. FUNDING NUMBERS Principles and Practice of Surveillance None 6. AUTHOR(S) Teutsch, Steven M. and CHoif.) 4il-^^o Churchill, R. Elliott, Editors 7. PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES) 8. PERFORMING ORGANIZATION REPORT NUMBER Epidemiology Program Office Centers for Disease Control Mail stop C08 Atlanta, GA 30333 None 9.
    [Show full text]
  • Revision of Clinical Case Definitions: Influenza-Like Illness and Severe Acute Respiratory Infection
    PolicyPolicy & practice & practice Revision of clinical case definitions: influenza-like illness and severe acute respiratory infection Julia Fitzner,a Saba Qasmieh,a Anthony Wayne Mounts,a Burmaa Alexander,b Terry Besselaar,a Sylvie Briand,a Caroline Brown,c Seth Clark,a Erica Dueger,d Diane Gross,c Siri Hauge,e Siddhivinayak Hirve,a Pernille Jorgensen,c Mark A Katz,f Ali Mafi,g Mamunur Malik,g Margaret McCarron,f Tamara Meerhoff,h Yuichiro Mori,a Joshua Mott,i Maria Teresa da Costa Olivera,j Justin R Ortiz,a Rakhee Palekar,k Helena Rebelo-de-Andrade,l Loes Soetens,m Ali Ahmed Yahaya,n Wenqing Zhanga & Katelijn Vandemaelea Abstract The formulation of accurate clinical case definitions is an integral part of an effective process of public health surveillance. Although such definitions should, ideally, be based on a standardized and fixed collection of defining criteria, they often require revision to reflect new knowledge of the condition involved and improvements in diagnostic testing. Optimal case definitions also need to have a balance of sensitivity and specificity that reflects their intended use. After the 2009–2010 H1N1 influenza pandemic, the World Health Organization (WHO) initiated a technical consultation on global influenza surveillance. This prompted improvements in the sensitivity and specificity of the case definition for influenza – i.e. a respiratory disease that lacks uniquely defining symptomology. The revision process not only modified the definition of influenza-like illness, to include a simplified list of the criteria shown to be most predictive of influenza infection, but also clarified the language used for the definition, to enhance interpretability.
    [Show full text]
  • The Epidemiology of Infectious Diseases in Illinois, 1999 TABLE of CONTENTS
    The Epidemiology of Infectious Diseases in Illinois, 1999 TABLE OF CONTENTS Reportable communicable diseases in Illinois..................................1 1999 summary of selected Illinois infectious diseases ...........................2 Acquired immune deficiency syndrome/Human immunodeficiency virus ............4 Amebiasis..............................................................9 Animal bites...........................................................11 Blastomycosis .........................................................13 Brucellosis............................................................15 Campylobacteriosis .....................................................16 Central nervous system infections ..........................................19 Aseptic meningitis .................................................19 Encephalitis .......................................................22 Bacterial meningitis ................................................27 Haemophilus influenzae (invasive disease) ..............................28 Listeriosis ........................................................30 Invasive Neisseria meningitidis .......................................31 Streptococcus pneumoniae meningitis ..................................35 Streptococcus, invasive group B .......................................38 Cryptosporidiosis.......................................................41 Ehrlichiosis ...........................................................44 E. coli O157:H7 ........................................................46
    [Show full text]
  • An Assessment of Illness in U.S. Government Employees and Their Families at Overseas Embassies (2020)
    THE NATIONAL ACADEMIES PRESS This PDF is available at http://nap.edu/25889 SHARE An Assessment of Illness in U.S. Government Employees and Their Families at Overseas Embassies (2020) DETAILS 76 pages | 8.5 x 11 | PAPERBACK ISBN 978-0-309-68137-7 | DOI 10.17226/25889 CONTRIBUTORS GET THIS BOOK David A. Relman and Julie A. Pavlin, Editors; Standing Committee to Advise the Department of State on Unexplained Health Effects on U.S. Government Employees and Their Families at Overseas Embassies; Health and Medicine Division; Division on Engineering and Physical Sciences; National Academies of Sciences, FIND RELATED TITLES Engineering, and Medicine SUGGESTED CITATION National Academies of Sciences, Engineering, and Medicine 2020. An Assessment of Illness in U.S. Government Employees and Their Families at Overseas Embassies. Washington, DC: The National Academies Press. https://doi.org/10.17226/25889. Visit the National Academies Press at NAP.edu and login or register to get: – Access to free PDF downloads of thousands of scientific reports – 10% off the price of print titles – Email or social media notifications of new titles related to your interests – Special offers and discounts Distribution, posting, or copying of this PDF is strictly prohibited without written permission of the National Academies Press. (Request Permission) Unless otherwise indicated, all materials in this PDF are copyrighted by the National Academy of Sciences. Copyright © National Academy of Sciences. All rights reserved. An Assessment of Illness in U.S. Government Employees and Their Families at Overseas Embassies An Assessment of Illness in U.S. Government Employees and Their Families at Overseas Embassies Standing Committee to Advise the Department of State on Unexplained Health Effects on U.S.
    [Show full text]
  • Third International Workshop on Chronic Kidney Diseases of Uncertain/Non-Traditional Etiology in Mesoamerica and Other Regions
    Report From the Third International Workshop on Chronic Kidney Diseases of Uncertain/Non-Traditional Etiology in Mesoamerica and Other Regions March 20-22, 2019 San José, Costa Rica Workshop organized by: Consortium for the Epidemic of Nephropathy in Central America and Mexico (CENCAM), National Institutes of Health: National Institute of Environmental Health Sciences (NIEHS) and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and World Health Organization Regional Offices: Pan American Health Organization (PAHO) and South-East Asia Regional Office (SEARO) Workshop organizing committee (in alphabetical order): Daniel Brooks (CENCAM), Ricardo Correa-Rotter (CENCAM), Jennifer Crowe (CENCAM), Marvin González-Quiroz (CENCAM), Kristina Jakobsson (CENCAM), Bonnie Joubert (NIEHS), Paul Kimmel (NIDDK), Ty Lawson (NIEHS), Susan Mendley (NIDDK), Brittany Trottier (NIEHS) Technical Series SALTRA Central American Program for Health, Work, and Environment (SALTRA) www.saltra.una.ac.cr 616.61 T14r Third International Workshop on Chronic Kidney Diseases of Uncertain/Non-Ttraditional Etiology in Mesoamerica and Other Regions (2019 Mar. 20-22: San José, Costa Rica) Report from the Third International Workshop on Chronic Kidney Diseases of Uncertain/Non-Traditional Etiology in Mesoamerica and Other Regions Editors: Jennifer L. Crowe, Bonnie R. Joubert, Daniel R. Brooks – Heredia, C.R.: SALTRA/IRET- UNA, 2020. 118 páginas: ilustraciones a color, fotografía. (Serie Salud; Trabajo y Ambiente; n° 36). Publicado también con la serie: Informe técnicos IRET, n° 38 ISBN 978-9968-924-35-1 1. RIÑONES, 2. ENFERMEDADES, 3. NEFROLOGIA, 4. EPIDEMIOLOGIA, 5. FISIOPATOLOGÍA, 6. ENFERMEDADES DEL APARATO URINARIO, 7. PLAGUICIDAS, 8. TRABAJO, 9. AGRICULTURA, 10. ENFERMEDADES OCUPACIONALES, 11. MESOAMÉRICA I. Crowe, Jennifer, editor, II.
    [Show full text]
  • Public Health Then and Now: Celebrating 50 Years of MMWR at CDC
    Morbidity and Mortality Weekly Report Supplement / Vol. 60 October 7, 2011 Public Health Then and Now: Celebrating 50 Years of MMWR at CDC January 15, 1993 / Vol. 42 / No. 1 CENTERS FOR DISEASE CONTROL AND PREVENTION 1 Hepatitis E Amon g U.S. T ravelers, 1989–1992 4 Surveillance of Deaths Attributed to a Nor’easter — December 1992 5 Respiratory Syncytial Virus Outbreak Activity — United States, 1992 7 Condom Use and Sexual Identity Am ong Men W ho Have Sex With Men — Dallas, 1991 14 Surveillance of the Health Status of Bhutanese Refugees — Nepal, 1992 17 Notice to Readers Morbidity and Mortality Weekly Report Weekly January 11, 2002 / Vol. 51 / No. 1 Epidemiologic Notes and Reports Rapid Assessment of Injuries Among Survivors of the Terrorist Attack Hepatitis E Among U.S. Travelers, 1989–1992 on the World Trade Center — New York City, September 2001 HepatitisOutbreaks E of— hepatitisContinued E (i.e., enterically transmitted non-A, non-B hepatitis) have occurred in some parts of the world and have generally been related to contaminated water supplies. Until recently, when research-based serologic tests ( 1,2 ) were devel- On September 11, 2001, a jet aircraft crashed into the north health-care services by survivors, the New York City Depart- oped to test for antibody to hepatitis E virus (anti-HEV), no serologic test was available tower of the World Trade Center (WTC) in lower Manhat- ment of Health (NYCDOH) conducted a field investigation to identify HEV infection, and diagnosis depended on a history of exposure in an ap- propriate epidemiologic setting and the exclusion of other causes of viral hepatitis.
    [Show full text]
  • Chronic Kidney Disease of Nontraditional Etiology in Central America: a Provisional Epidemiologic Case Definition for Surveillance and Epidemiologic Studies
    Pan American Journal Current topic of Public Health nontraditional etiology (CKDnT). According to the Pan Chronic kidney disease American Health Organization (PAHO) mortality database, there are elevated rates of deaths related to kidney disease in of nontraditional etiology many of these countries, with the highest rates being reported in El Salvador and Nicaragua. This condition has been iden- in Central America: a tified in certain agricultural communities, predominantly among male farmworkers. Since CKD surveillance systems provisional in Central America are under development or nonexistent, experts and governmental bodies have recommended creat- epidemiologic case ing standardized case definitions for surveillance purposes to monitor and characterize this epidemiological situation. A definition for group of experts from Central American ministries of health, the U.S. Centers for Disease Control and Prevention (CDC), surveillance and and PAHO held a workshop in Guatemala to discuss CKDnT epidemiologic case definitions. In this paper, we propose that CKD in general be identified by the standard definition epidemiologic studies internationally accepted and that a suspect case of CKDnT be defined as a person age < 60 years with CKD, without type 1 diabetes mellitus, hypertensive diseases, and other well-known causes of CKD. A probable case of CKDnT is Matthew Lozier,1 defined as a suspect case with the same findings confirmed three or more months later. Reina Maria Turcios-Ruiz,2 Gary Noonan,3 Key words: Renal insufficiency, chronic; kidney diseases; nephritis; chronic disease; epidemiological 4 and Pedro Ordunez surveillance; diagnosis, differential; Central America. Suggested citation Lozier M, Turcios-Ruiz RM, Noonan G, Ordunez P. Chronic kidney disease of nontraditional etiology in Central America: a provisional epidemiologic case definition for surveillance and epidemiologic studies.
    [Show full text]
  • The Brighton Collaboration: Creating a Global Standard for Case Definitions (And Guidelines) for Adverse Events Following Immunization
    The Brighton Collaboration: Creating a Global Standard for Case Definitions (and Guidelines) for Adverse Events Following Immunization Katrin S. Kohl, Jan Bonhoeffer, M. Miles Braun, Robert T. Chen, Philippe Duclos, Harald Heijbel, Ulrich Heininger, Elisabeth Loupi, S. Michael Marcy, the Brighton Collaboration Abstract Background: To advance the science of immunization safety and “vaccinovigilance,” a globally acceptable, common vocabulary for adverse events following immunization (AEFIs) is needed to promote comparability of data. Methods: The Brighton Collaboration develops standardized case definitions and guidelines for data collection, analysis, and presentation via participation of more than 500 experts from 57 countries from public health, clinical care, academia, regulatory organizations, and industry. Results: The first six Brighton case definitions and guidelines have been finalized. Work continues on 17 additional topics. Formal evaluation studies of definitions are underway. More than 67 investigators in 30 countries have begun or are considering implementation of the definitions and guidelines. Conclusions: Standardized and globally implemented case definitions and guidelines for AEFIs will enhance comparability of vaccine safety data and ultimately maintain trust in immunization programs worldwide. The Brighton Collaboration may be a useful model for other realms of patient safety. Introduction Why is immunization safety research important? Immunizations are extremely powerful public health interventions due to their high cost-effectiveness, safety, and efficacy. Few other medical interventions have such long-lasting positive impact, given the relatively minor acute costs associated with immunizations. However, unlike most drugs, immunizations are usually given to healthy, young individuals for preventive purposes and thus merit special attention to their safety. In 1974, the World Health Organization (WHO) launched its Expanded Programme on Immunization (EPI).
    [Show full text]
  • Operational Guidelines on Kala-Azar (Visceral Leishmaniasis) Elimination in India - 2015
    OPERATIONAL GUIDELINES ON KALA-AZAR (VISCERAL LEISHMANIASIS) ELIMINATION IN INDIA - 2015 October 2015 NATIONAL VECTOR BORNE DISEASE CONTROL PROGRAMME MINISTRY OF HEALTH & FAMILY WELFARE DIRECTORATE GENERAL OF HEALTH SERVICES DMRC Building, Block-III,Ground Floor, Delhi IT Park, Shastri Park, DELHI - 110053 www.nvbdcp.gov.in Kala-azar has been declared as “Notifiable disease” in Bihar and West Bengal Preface Visceral Leishmaniasis commonly known as Kala-azar is a parasitic disease prevalent in 4 states with approximately 130 million population living in the endemic areas and at the risk of acquiring infection. Of the four states namely Bihar, Jharkhand, West Bengal and Uttar Pradesh, Bihar alone contributes more than 60% of the cases. Currently 54 districts in the states of Bihar, Jharkhand, Uttar Pradesh and West Bengal are endemic for Kala-azar. Due to intensified efforts by the centre and the participating states, significant reduction in the number of Kala-azar cases and deaths has been achieved at the end of 2014 It is needless to emphasize that GoI is according top priority towards Kala-azar elimination and the states are also providing ownership to the programme. Kala- azar programme strategies have seen significant changes on account of introduction of newer tools (Diagnostics and drugs) that has necessitated changes in the strategy and development of revised guidelines for use at all levels of implementation. Based on these developments, it was felt that comprehensive technical guidelines on Kala-azar elimination be developed encompassing all the programme components so that the implementation of the programme strategies becomes user friendly at all levels.
    [Show full text]
  • Evaluation of the Diagnostic Utility of the New Clinical Case Definition of Pertussis–Experience from Sentinel and Hospital-Based Pertussis Surveillance
    DOI: https://doi.org/10.2298/SARH180413022R UDC: 616.921.8-074 443 ORIGINAL ARTICLE / ОРИГИНАЛНИ РАД Evaluation of the diagnostic utility of the new clinical case definition of pertussis – experience from sentinel and hospital-based pertussis surveillance Mioljub Ristić1,2, Vesna D. Stojanović1,3, Vladimir Petrović1,2, Ulrich Heininger4 1University of Novi Sad, Faculty of Medicine, Novi Sad, Serbia; 2Institute of Public Health of Vojvodina, Novi Sad, Serbia; 3Institute for Child and Youth Health Care of Vojvodina, Novi Sad, Serbia; 4University Children’s Hospital Basel (UKBB), Basel, Switzerland SUMMARY Introduction/Objective Global surveillance systems use different clinical case definitions of pertussis. The aim of this study was to identify sign and symptom combinations with best relation with laboratory- confirmed pertussis. Methods A one-year prospective observational study, proposed by the Global Pertussis Initiative (GPI) for three age groups (0–3 months, four months to nine years, and ≥ 10 years) was performed in Novi Sad to evaluate the performance of the clinical case definition of pertussis. Laboratory confirmation of B. pertussis infection was obtained using the DNA polymerase chain reaction (PCR) or ELISA serology tests. Results From October 1, 2013 to September 30, 2014, 103 (32.3%) out of 319 participants with suspected pertussis had laboratory-confirmed pertussis. Combined whooping, post-tussive emesis, and worsening of symptoms at night was the best predictor of pertussis in outpatients aged four months to nine years (positive likelihood ratio (LR+) 11.6), while among inpatients of the same age group it was apnoea (LR+ 13.5). The LR+ in outpatients aged ≥10 years for combinations of apnoea and post-tussive emesis, or a combination of whooping and sweating episodes between paroxysms and post-tussive emesis was 16.8, while among in-patients LR+ was < 2.3 for all combinations in the same age group.
    [Show full text]